NCT00402883 2021-11-09
Chemotherapy, Radiotherapy and Bevacizumab in Patients With Unresectable Stage III Non-Small-Cell Lung Cancer
SCRI Development Innovations, LLC
Phase 2 Terminated
SCRI Development Innovations, LLC
Case Comprehensive Cancer Center
Texas Tech University Health Sciences Center, El Paso
Massachusetts General Hospital
Stanford University
New Mexico Cancer Research Alliance
Memorial Sloan Kettering Cancer Center